With 422 million people worldwide living with diabetes, delayed wound healing remains a significant clinical challenge affecting a substantial portion of this population. Many diabetic patients experience chronic wounds that resist standard care protocols, creating urgent demand for novel therapeutic approaches.
New research from the National University of Singapore addresses this critical gap through artificial intelligence-driven drug discovery. The AI workflow identified folic acid as a potential treatment targeting the impaired wound-healing mechanisms characteristic of diabetic patients. The computational screening process achieved 85 percent efficiency, compared to 35 percent for high-throughput screening and 15 percent for traditional methods.
This advancement represents a substantial improvement in identifying therapeutic candidates from large compound libraries. By leveraging molecular dynamics simulations alongside AI algorithms, researchers can now accelerate the path from computational discovery to clinical application for diabetic wound care. Read the full article on GMJ Newsroom.
Was this article helpful?
